Skip to main navigation

English
Français

IR Navigation

Overview
News
Events & Presentations
- Events
- Presentations
Stock Information
Financials
Governance
Resources

Press Releases

Press Releases

Year

20 Sep 2023

GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update

05 Sep 2023

GENFIT to Participate in Upcoming Investor Conferences

10 Aug 2023

GENFIT Announces the Publication of New Data on the Clinical Performance of NIS2+™ in Older Patients in Hepatology Communications

12 Jul 2023

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

30 Jun 2023

Ipsen and GENFIT Announce Positive Results from Phase III ELATIVE® trial of elafibranor in patients with primary biliary cholangitis, a rare cholestatic liver disease

07 Jun 2023

GENFIT Announces New Data at the European Association for the Study of the Liver (EASL) Congress 2023

31 May 2023

GENFIT Further Strengthens its ACLF Franchise with a Third Clinical-Stage Asset

24 May 2023

GENFIT: May 24, 2023 Combined Shareholders Meeting results

23 May 2023

GENFIT Announces Publication of the Development and Validation of NIS2+™ in the Journal of Hepatology

11 May 2023

GENFIT Reports First Quarter 2023 Financial Information

09 May 2023

GENFIT Presents Phase 1 Clinical Data Evaluating NTZ at Digestive Disease Week® as part of its ACLF Program

27 Apr 2023

GENFIT Announces Publication of Extra-Financial Performance Report 2022

19 Apr 2023

GENFIT Annual Combined General Meeting of May 24, 2023 — Availability of Preparatory Documents

18 Apr 2023

GENFIT Announces Publication of the 2022 Universal Registration Document and the 2022 Annual Report on Form 20-F

13 Apr 2023

GENFIT Reports Full-Year 2022 Financial Results and Provides Corporate Update

28 Feb 2023

GENFIT Announces Revenues and Cash Position as of December 31, 2022

30 Jan 2023

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

24 Jan 2023

GENFIT Announces 2023 Financial Calendar

05 Jan 2023

GENFIT to Participate in Upcoming Investor Conferences

Shareholder Tools

Print Page
Email Alerts
RSS
Contact IR

Request E-mail Alerts

GENFIT Headquarters
Parc Eurasanté 885, Avenue Eugène Avinée 59120 Loos France GENFIT Corp
45 Propect St. Suite 214, Cambridge, MA02139, USA

All rights reserved.